WASHINGTON — The Biden administration backed off some of its plans to rein in billions of dollars from wasteful spending in ...

Amid treaty talks to create equitable access to medical products during pandemics, the European Union has proposed pricing ...

Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed to follow numerous ...

Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drug makers increased their ...

"It tells you that when two groups of people with different ancestry get the same treatment for the same subtype of cancer, ...

As states across the U.S. introduce anti-trans legislation, transgender and nonbinary people face increasing restrictions in their ability to access gender-affirming care. Now experts say the ...

Lisa Barnes runs one of the nation’s largest studies of Alzheimer’s disease focused exclusively on Black people and has ...

A federal judge Thursday reversed a major Obamacare provision requiring plans to cover preventive care ranging from cancer ...

The U.S.'s usual, reactive approach to disease — wait for it to spring up before starting the work — is not a sustainable ...

It looks like the Solicitor General is siding with Teva by requesting the Supreme Court” to review the case, said Aziz Burgy, ...

A new CDC study highlights just how violent the recent past has been in the U.S. by showing a surge in people wounded by ...

Mathai Mammen, who until recently led research at Johnson & Johnson, will become the CEO of a privately held biotech company ...